Valo Overview
- Status
-
Private
- Employees
-
166
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$100M
- Investors
-
16
Valo General Information
Description
Developer of a health tech platform designed to facilitate the drug discovery and development process. The company's platform integrates machine learning, cloud computing, and data to analyze human data to uncover previously unsuspected associations between genetic markers and disease with a human-centric framing, enabling clients from the healthcare industry to develop oncology, neurodegenerative, and cardiovascular disease drugs.
Contact Information
Website
www.valohealth.comCorporate Office
- 75 Hayden Road
- Suite 200
- Lexington, MA 02421
- United States
Corporate Office
- 75 Hayden Road
- Suite 200
- Lexington, MA 02421
- United States
Valo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 28-Oct-2022 | $100M | Completed | Generating Revenue | ||
| 4. Early Stage VC (Series B) | 11-Mar-2021 | Completed | Generating Revenue | |||
| 3. Debt - General | 01-May-2020 | Completed | Stealth | |||
| 2. Debt - General | 01-Jan-2020 | $60M | $160M | Completed | Stealth | |
| 1. Early Stage VC (Series A) | 05-Jul-2019 | $100M | $100M | Completed | Stealth |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Valo Comparisons
Industry
Financing
Details
Valo Competitors (14)
One of Valo’s 14 competitors is Cyclica, a Formerly VC-backed company based in Toronto, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cyclica | Formerly VC-backed | Toronto, Canada | ||||
| Chemical Computing Group | Private Equity-Backed | Montreal, Canada | ||||
| Genesis Therapeutics | Venture Capital-Backed | Burlingame, CA | ||||
| Verge Genomics | Venture Capital-Backed | South San Francisco, CA | ||||
| insitro | Venture Capital-Backed | South San Francisco, CA |
Valo Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Valo Patents
Valo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4402129-A1 | Pending | 01-Aug-2022 | |||
| AU-2023320331-A1 | Process for preparing 6-substituted-1-(2h)-isoquinolinones and intermediate compound | Pending | 01-Aug-2022 | ||
| US-20240287030-A1 | Process for preparing 6-substituted-1-(2h)-isoquinolinones and intermediate compound | Pending | 01-Aug-2022 | ||
| US-20240287031-A1 | Process for preparing 6-substituted-1-(2h)-isoquinolinones and intermediate compound | Pending | 01-Aug-2022 | ||
| EP-4536216-A1 | Tricyclic phthalazinone parp inhibitors and methods of use | Pending | 08-Jun-2022 | C07D471/16 |
Valo Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Valo Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HBM Healthcare Investments | Venture Capital | Minority | ||
| Atinum Investment | Venture Capital | Minority | ||
| E Squared Capital Management | Hedge Fund | Minority | ||
| Hercules Capital | Lender/Debt Provider | Minority | ||
| Koch Disruptive Technologies | Venture Capital | Minority |
Valo Investments & Acquisitions (5)
Valo’s most recent deal was a Early Stage VC with Basecamp Research for . The deal was made on 01-Dec-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Basecamp Research | 01-Dec-2022 | Early Stage VC | Media and Information Services (B2B) | ||
| TARA Biosystems | 01-Apr-2022 | Merger/Acquisition | Biotechnology | ||
| Courier Therapeutics | 28-May-2021 | Merger/Acquisition | Drug Discovery | ||
| Numerate | 01-Nov-2019 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| TrialzOWN | 01-Mar-2019 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Valo Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Courier Therapeutics | Houston, TX | 2015 | |
| Numerate | San Francisco, CA | 2007 |
Valo FAQs
-
Where is Valo headquartered?
Valo is headquartered in Lexington, MA.
-
What is the size of Valo?
Valo has 166 total employees.
-
What industry is Valo in?
Valo’s primary industry is Discovery Tools (Healthcare).
-
Is Valo a private or public company?
Valo is a Private company.
-
What is the current valuation of Valo?
The current valuation of Valo is .
-
What is Valo’s current revenue?
The current revenue for Valo is .
-
How much funding has Valo raised over time?
Valo has raised $595M.
-
Who are Valo’s investors?
HBM Healthcare Investments, Atinum Investment, E Squared Capital Management, Hercules Capital, and Koch Disruptive Technologies are 5 of 16 investors who have invested in Valo.
-
Who are Valo’s competitors?
Cyclica, Chemical Computing Group, Genesis Therapeutics, Verge Genomics, and insitro are some of the 14 competitors of Valo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
